The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

Elon Musk’s substantial support for Donald Trump’s re-election has the potential to reshape regulatory oversight across his ...

Michelle Tarver, MD, PhD, a 15-year veteran of the agency, is stepping into a pivotal role as the new director of the FDA's device division, taking over for Jeffrey Shuren, MD. Dr. Shuren's tenure was ...

Christina JewettThere are now artificial intelligence programs that scan MRIs for signs of cancer, Apple AirPods that work as ...

Tom Oxley, the Australian-born chief executive of brain chip company Synchron, has praised ­Donald Trump for having a ...

Elon Musk's support for Trump could lead to significant policy shifts benefiting his companies. His potential role in the new ...

Elon Musk’s backing of Donald Trump’s decisive victory for a second presidency gives the billionaire entrepreneur ...

The world's richest person could get a lot of help with contracts and regulatory headaches during the Trump administration.

Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.

Musk has business interests that depend heavily on government regulation, subsidies or policy, from Tesla’s electric cars to ...

Musk donated at least $119 million to a pro-Trump political action committee and vocally supported the former US president during the campaign’s final stretch, according to federal records.